Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors

Nature Medicine

Volumn 18, Issue 9, 2012, Pages 1429-1433

  McCurley, Amy ^a   Pires, Paulo W ^b   Bender, Shawn B ^c   Aronovitz, Mark ^d   Zhao, Michelle J ^d   Metzger, Daniel ^e   Chambon, Pierre ^e   Hill, Michael A ^f   Dorrance, Anne M ^b   Mendelsohn, Michael E ^a,g   Jaffe, Iris Z ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c University of Missouri   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f UNIVERSITY OF MISSOURI   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; MINERALOCORTICOID RECEPTOR; 5 BROMO 4 CHLORO 3 INDOLYL BETA GALACTOSIDE; 5-BROMO-4-CHLORO-3-INDOLYL BETA-GALACTOSIDE; GALACTOSIDE; INDOLE DERIVATIVE; PRIMER DNA; SODIUM;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; HYPERTENSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOOTH MUSCLE; ANIMAL; BLOOD PRESSURE; CYTOLOGY; GENETICS; HEART; HISTOLOGY; METABOLISM; MUSCLE CONTRACTION; ORGAN SIZE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

MUS;

AGING; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNELS, L-TYPE; DNA PRIMERS; GALACTOSIDES; HEART; INDOLES; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN SIZE; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, MINERALOCORTICOID; SODIUM;

EID: 84868662652     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2891     Document Type: Article

References (40)

1. Gradman, A.H. Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 years. Drugs Aging 26, 751-767 (2009).
2. Logan, A.G. Hypertension in aging patients. Expert Rev. Cardiovasc. Ther. 9, 113-120 (2011).
3. Bhargava, A., Wang, J. & Pearce, D. Regulation of epithelial ion transport by aldosterone through changes in gene expression. Mol. Cell. Endocrinol. 217, 189-196 (2004).
4. McCurley, A. & Jaffe, I.Z. Mineralocorticoid receptors in vascular function and disease. Mol. Cell. Endocrinol. 350, 256-265 (2012).
5. Jaffe, I.Z. et al. Placental growth factor mediates aldosterone-dependent vascular injury in mice. J. Clin. Invest. 120, 3891-3900 (2010).
6. Levy, D.G., Rocha, R. & Funder, J.W. Distinguishing the antihypertensive and electrolyte effects of eplerenone. J. Clin. Endocrinol. Metab. 89, 2736-2740 (2004).
7. Nguyen Dinh Cat, A. et al. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J. 24, 2454-2463 (2010).
8. Stolarz-Skrzypek, K. et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. J. Am. Med. Assoc. 305, 1777-1785 (2011).
9. Taylor, R.S., Ashton, K.E., Moxham, T., Hooper, L. & Ebrahim, S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials. Am. J. Hypertens. 24, 843-853 (2011).
10. Funder, J.W., Pearce, P.T., Smith, R. & Campbell, J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 125, 2224-2226 (1989).
11. Jaffe, I.Z. & Mendelsohn, M.E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ. Res. 96, 643-650 (2005).
12. Rogerson, F.M. & Fuller, P.J. Mineralocorticoid action. Steroids 65, 61-73 (2000).
13. Berger, S. et al. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc. Natl. Acad. Sci. USA 95, 9424-9429 (1998).
14. + metabolism. Kidney Int. 57, 1295-1298 (2000).
15. Ronzaud, C. et al. Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. J. Am. Soc. Nephrol. 18, 1679-1687 (2007).
16. Ronzaud, C., Loffing, J., Gretz, N., Schutz, G. & Berger, S. Inducible renal principal cell-specific mineralocorticoid receptor gene inactivation in mice. Am. J. Physiol. Renal Physiol. 300, F756-F760 (2011).
17. Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341, 709-717 (1999).
18. Pitt, B. et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321 (2003).
19. Zannad, F. et al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. 364, 11-21 (2011).
20. Funder, J.W. & Mihailidou, A.S. Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology. Mol. Cell. Endocrinol. 301, 2-6 (2009).
21. Wendling, O., Bornert, J.M., Chambon, P. & Metzger, D. Efficient temporally-controlled targeted mutagenesis in smooth muscle cells of the adult mouse. Genesis 47, 14-18 (2009).
22. Ledoux, J., Werner, M.E., Brayden, J.E. & Nelson, M.T. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 21, 69-78 (2006).
23. Ambroisine, M.L. et al. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells. Circulation 116, 2435-2443 (2007).
24. Krug, A.W. et al. Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension 55, 1476-1483 (2010).
25. Cassis, P., Conti, S., Remuzzi, G. & Benigni, A. Angiotensin receptors as determinants of life span. Pflugers Arch. 459, 325-332 (2010).
26. Ungvari, Z., Kaley, G., de Cabo, R., Sonntag, W.E. & Csiszar, A. Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65, 1028-1041 (2010).
27. Xue, B., Pamidimukkala, J. & Hay, M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am. J. Physiol. Heart Circ. Physiol. 288, H2177-H2184 (2005).
28. Touyz, R.M. Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz. J. Med. Biol. Res. 37, 1263-1273 (2004).
29. Rautureau, Y., Paradis, P. & Schiffrin, E.L. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Steroids 76, 834-839 (2011).
30. Mendelsohn, M.E. In hypertension, the kidney is not always the heart of the matter. J. Clin. Invest. 115, 840-844 (2005).
31. Id, D., Bertog, S.C., Wunderlich, N. & Sievert, H. Catheter-based renal sympathectomy. J. Cardiovasc. Surg. (Torino) 51, 721-739 (2010).
32. Sellers, M.M. & Stallone, J.N. Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure. Am. J. Physiol. Heart Circ. Physiol. 294, H1978-H1986 (2008).
33. Poulsen, C.B., Al-Mashhadi, R.H., Cribbs, L.L., Skott, O. & Hansen, P.B. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles. Kidney Int. 79, 443-451 (2011).
34. Wang, W., Pang, L. & Palade, P. Angiotensin II upregulates Ca(V)1.2 protein expression in cultured arteries via endothelial H(2)O(2) production. J. Vasc. Res. 48, 67-78 (2011).
35. Metzger, D., Clifford, J., Chiba, H. & Chambon, P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 92, 6991-6995 (1995).
36. Newfell, B.G. et al. Aldosterone regulates vascular gene transcription via oxidative stress-dependent and-independent pathways. Arterioscler. Thromb. Vasc. Biol. 31, 1871-1880 (2011).
37. Zhu, Y. et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 295, 505-508 (2002).
38. Pires, P.W. et al. Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 301, H87-H97 (2011).
39. Rigsby, C.S., Pollock, D.M. & Dorrance, A.M. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc. Res. 73, 198-205 (2007).
40. Yang, Y. et al. Heterogeneity in function of small artery smooth muscle BKCa: involvement of the β1-subunit. J. Physiol. (Lond.) 587, 3025-3044 (2009).